MORE Savings Act
The source supplies the latest action, but no lifecycle stage.
Latest action (3 Sep 2026): Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Education and Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
What this bill does
H.R. 10254, the MORE Savings Act, addresses cost barriers to opioid use disorder treatment across several federal programs. It directs the Center for Medicare and Medicaid Innovation to test a model in 15 states—selected for high Medicare enrollment, high opioid overdose death rates, and significant rural population—that eliminates Medicare coinsurance, copayments, and deductibles for opioid-related drugs, behavioral health services, and recovery support services such as peer counseling and transportation. The model would run for at least five years before standard termination rules apply. The bill also amends federal insurance law (covering the Public Health Service Act, ERISA, and the tax code) to require group and individual health plans, starting with plan years on or after January 1, 2027, to cover opioid use disorder medications, behavioral health treatment, and recovery support services without any cost-sharing. Additionally, it raises the federal Medicaid matching rate to 90 percent for medication-assisted treatment and allows states to include recovery support services under that Medicaid benefit.
The bill primarily affects Medicare beneficiaries in the selected pilot states, individuals covered by employer or individual health insurance plans nationwide, and state Medicaid programs. Health insurers, employers sponsoring health plans, and state Medicaid agencies would need to adjust coverage and cost-sharing policies accordingly.
The bill was introduced on September 3, 2026, by Rep. Madeleine Dean and referred to the House Committees on Energy and Commerce, Ways and Means, and Education and Workforce. It has not yet received committee action, a vote, or been enacted, and would need to pass both chambers of Congress and be signed by the President to become law.
Plain-English summary generated by Bill100 AI from the official record. Always verify against the source below.
Official summary
Maximizing Opioid Recovery Emergency Savings Act or the MORE Savings Act
This bill modifies coverage of opioid treatments and recovery support services under Medicare, Medicaid, and private health insurance.
Specifically, the bill requires the Center for Medicare and Medicaid Innovation to test a model in which specified opioid treatments and recovery support services are provided under Medicare without cost-sharing (e.g., coinsurance, copayments, and deductibles).
The bill also allows state Medicaid programs to cover recovery support services as part of medication-assisted treatment (MAT) and increases the applicable Federal Medical Assistance Percentage for MAT.
Additionally, beginning in 2027, private health insurers must cover specified opioid treatments and MAT-associated recovery support services without cost-sharing.
Timeline
3 Sep 2026
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Education and Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Common questions
- What does H.R. 10254 do?
- H.R. 10254, the MORE Savings Act, addresses cost barriers to opioid use disorder treatment across several federal programs. It directs the Center for Medicare and Medicaid Innovation to test a model in 15 states—selected for high Medicare enrollment, high opioid overdose death rates, and significant rural population—that eliminates Medicare coinsurance, copayments, and deductibles for opioid-related drugs, behavioral health services, and recovery support services such as peer counseling and transportation. The model would run for at least five years before standard termination rules apply. The bill also amends federal insurance law (covering the Public Health Service Act, ERISA, and the tax code) to require group and individual health plans, starting with plan years on or after January 1, 2027, to cover opioid use disorder medications, behavioral health treatment, and recovery support services without any cost-sharing. Additionally, it raises the federal Medicaid matching rate to 90 percent for medication-assisted treatment and allows states to include recovery support services under that Medicaid benefit. The bill primarily affects Medicare beneficiaries in the selected pilot states, individuals covered by employer or individual health insurance plans nationwide, and state Medicaid programs. Health insurers, employers sponsoring health plans, and state Medicaid agencies would need to adjust coverage and cost-sharing policies accordingly. The bill was introduced on September 3, 2026, by Rep. Madeleine Dean and referred to the House Committees on Energy and Commerce, Ways and Means, and Education and Workforce. It has not yet received committee action, a vote, or been enacted, and would need to pass both chambers of Congress and be signed by the President to become law.
- Has H.R. 10254 become law?
- The source does not supply a confirmed lifecycle stage for H.R. 10254. Check the latest action and official source below.
- Who sponsored H.R. 10254?
- H.R. 10254 was sponsored by Rep. Dean, Madeleine [D-PA-4] (D-PA), with 0 cosponsors.
- What's the latest action on H.R. 10254?
- Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Education and Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. (3 Sep 2026).
Related bills in Health
Choices for Increased Mobility Act of 2026
Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026
Lower Premiums, Faster Payments Act
Access to Medical Supplies Act
More bills from Rep. Dean, Madeleine [D-PA-4]
To establish a Science Advisory Board at the Department of Justice, and for other purposes.
AID Local Government Leadership Act
Beyond the Box for Higher Education Act of 2026
Removing Access Barriers to Running for Elected Office for People with Disabilities Act
Bill100 mirrors the public U.S. legislative record from Congress.gov and GovTrack and adds plain-English AI summaries. It is an information tool, not legal, compliance or lobbying advice, and it is not affiliated with the U.S. Congress or any government agency. AI summaries can simplify or omit detail — every bill links to the official source; verify there before you rely on it.